These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38013112)

  • 1. The role of gut microbiota and metabolites in cancer chemotherapy.
    Li S; Zhu S; Yu J
    J Adv Res; 2023 Nov; ():. PubMed ID: 38013112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy.
    Deng Y; Hou X; Wang H; Du H; Liu Y
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.
    Yue B; Gao R; Wang Z; Dou W
    Front Cell Infect Microbiol; 2021; 11():710945. PubMed ID: 34722328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress on the effect of gut and tumor microbiota on antitumor efficacy and adverse effects of chemotherapy drugs.
    Yin B; Wang X; Yuan F; Li Y; Lu P
    Front Microbiol; 2022; 13():899111. PubMed ID: 36212852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota: a key orchestrator of cancer therapy.
    Roy S; Trinchieri G
    Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer.
    Xu Y; Du H; Chen Y; Ma C; Zhang Q; Li H; Xie Z; Hong Y
    Crit Rev Microbiol; 2023 Jul; ():1-17. PubMed ID: 37439132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy.
    Cheng P; Shen P; Shan Y; Yang Y; Deng R; Chen W; Lu Y; Wei Z
    Front Cell Dev Biol; 2021; 9():626045. PubMed ID: 34568308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives.
    Liu J; Tan Y; Cheng H; Zhang D; Feng W; Peng C
    Aging Dis; 2022 Jul; 13(4):1106-1126. PubMed ID: 35855347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment.
    Pouncey AL; Scott AJ; Alexander JL; Marchesi J; Kinross J
    Ecancermedicalscience; 2018; 12():868. PubMed ID: 30263059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplays between drugs and the gut microbiome.
    Wan Y; Zuo T
    Gastroenterol Rep (Oxf); 2022; 10():goac009. PubMed ID: 35401987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions.
    Dey P
    Pharmacol Res; 2019 Sep; 147():104367. PubMed ID: 31344423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: A magical multifunctional target regulated by medicine food homology species.
    Zuo WF; Pang Q; Yao LP; Zhang Y; Peng C; Huang W; Han B
    J Adv Res; 2023 Oct; 52():151-170. PubMed ID: 37269937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota as an "invisible organ" that modulates the function of drugs.
    Li X; Liu L; Cao Z; Li W; Li H; Lu C; Yang X; Liu Y
    Biomed Pharmacother; 2020 Jan; 121():109653. PubMed ID: 31810138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review.
    Cheng H; Zhang D; Wu J; Liu J; Zhou Y; Tan Y; Feng W; Peng C
    Phytomedicine; 2023 Oct; 119():154979. PubMed ID: 37552899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between gut microbiota and tumour chemotherapy.
    Liu L; Bai Y; Xiang L; Qi W; Gao L; Li X; Li H; Wang B; Chen H
    Clin Transl Oncol; 2022 Dec; 24(12):2330-2341. PubMed ID: 36103048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy.
    Li B; Gong T; Hao Y; Zhou X; Cheng L
    Front Oncol; 2021; 11():721249. PubMed ID: 34589427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.
    Chen Y; Liao X; Li Y; Cao H; Zhang F; Fei B; Bao C; Cao H; Mao Y; Chen X; Gao X; Zhao W; Xu J
    Trials; 2023 Apr; 24(1):268. PubMed ID: 37046334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.